GlassScriptSymbia Pro.Specta X3
Payments companies reported to CMS as associated with Symbia Pro.Specta X3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Symbia Pro.Specta X3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Symbia Pro.Specta X3
These are the largest totals companies reported as associated with Symbia Pro.Specta X3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Julia Nguyen | Milwaukee, WI | Nurse Practitioner | $180.43 |
| Russ Kuker | Miami, FL | Nuclear Medicine | $142.10 |
| Jackson Kiser | Roanoke, VA | Diagnostic Radiology | $112.66 |
| Jana Ivanidze | New York, NY | Diagnostic Radiology | $94.88 |
| Amish Doshi | New York, NY | Diagnostic Radiology | $93.96 |
| Samuel Mehr | Omaha, NE | Nuclear Medicine | $25.17 |
| Paul Jabour | Clive, IA | Diagnostic Radiology | $18.40 |
| Arshin Sheybani | Des Moines, IA | Radiation Oncology | $18.40 |
| David Lacey | Clive, IA | Vascular & Interventional Radiology | $18.40 |
| Samuel Schroeder | Des Moines, IA | Radiation Oncology | $18.40 |
Prescribed Symbia Pro.Specta X3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.